chr17-74863920-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_024417.5(FDXR):c.1150G>A(p.Glu384Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000266 in 1,613,794 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024417.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDXR | NM_024417.5 | c.1150G>A | p.Glu384Lys | missense_variant | 10/12 | ENST00000293195.10 | NP_077728.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDXR | ENST00000293195.10 | c.1150G>A | p.Glu384Lys | missense_variant | 10/12 | 1 | NM_024417.5 | ENSP00000293195 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000168 AC: 42AN: 250708Hom.: 1 AF XY: 0.000185 AC XY: 25AN XY: 135460
GnomAD4 exome AF: 0.000278 AC: 406AN: 1461552Hom.: 1 Cov.: 31 AF XY: 0.000292 AC XY: 212AN XY: 727084
GnomAD4 genome AF: 0.000151 AC: 23AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74382
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 20, 2023 | The c.1168G>A (p.E390K) alteration is located in exon 10 (coding exon 10) of the FDXR gene. This alteration results from a G to A substitution at nucleotide position 1168, causing the glutamic acid (E) at amino acid position 390 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | FDXR: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at